AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32051005 — intervention group
Group type: COMPARATOR
Intervention: Usual care (best-practice discharge processes including educational materials, assistance with outpatient appointments, referrals to community-based providers)
Number of subjects: 0
Study 34203924 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapies with transference interpretations
Number of subjects: 0
Study 34203924 — intervention group
Group type: COMPARATOR
Intervention: Therapies without transference interpretations
Number of subjects: 0
Study 32988624 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib (300mg oral tablets, twice daily for 28 days)
Number of subjects: 31
Study 35692186 — intervention group
Group type: EXPERIMENTAL
Intervention: THC (13-49 mg)
Number of subjects: 85
Study 33076928 — intervention group
Group type: EXPERIMENTAL
Intervention: Olyset® Net
Number of subjects: 254
Study 33076928 — intervention group
Group type: COMPARATOR
Intervention: DawaPlus® 2.0
Number of subjects: 254
Study 33097097 — intervention group
Group type: EXPERIMENTAL
Intervention: NIATx-TI implementation strategy (change management training and coaching on mobile application use)
Number of subjects: 46
Study 33097097 — intervention group
Group type: COMPARATOR
Intervention: Typical software product training (in-person staff training followed by online support)
Number of subjects: 46
Study 36158972 — intervention group
Group type: EXPERIMENTAL
Intervention: Real acupuncture treatment
Number of subjects: 60
Study 36158972 — intervention group
Group type: COMPARATOR
Intervention: Sham acupuncture control
Number of subjects: 60
Study 35896910 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminiscence therapy plus usual care (RTUC)
Number of subjects: 160
Study 35896910 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 160
Study 33243221 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg or 25 mg)
Number of subjects: 7020
Study 33243221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7020
Study 34074815 — intervention group
Group type: EXPERIMENTAL
Intervention: Tip-in EMR
Number of subjects: 82
Study 34074815 — intervention group
Group type: COMPARATOR
Intervention: EMR
Number of subjects: 82
Study 34074815 — intervention group
Group type: COMPARATOR
Intervention: Tip-in EMR vs EMR
Number of subjects: 82
Study 32678211 — intervention group
Group type: EXPERIMENTAL
Intervention: High rebound (HR) mattress toppers
Number of subjects: 74
Study 32678211 — intervention group
Group type: COMPARATOR
Intervention: Low rebound (LR) mattress toppers
Number of subjects: 74
Study 32678211 — intervention group
Group type: COMPARATOR
Intervention: Spring mattresses without a topper
Number of subjects: 74
Study 36198292 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-restricted eating (TRE)
Number of subjects: 131
Study 36198292 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT)
Number of subjects: 131
Study 36198292 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of TRE and HIIT (TREHIIT)
Number of subjects: 131
Study 36198292 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-intervention)
Number of subjects: 131
Study 33572738 — intervention group
Group type: EXPERIMENTAL
Intervention: Flywheel strength training (FST)
Number of subjects: 36
Study 33572738 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional strength training (TST)
Number of subjects: 36
Study 33572738 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 36
Study 32660494 — intervention group
Group type: EXPERIMENTAL
Intervention: Korean tariff
Number of subjects: 12085
Study 32660494 — intervention group
Group type: EXPERIMENTAL
Intervention: Chinese (city) tariff
Number of subjects: 12085
Study 32660494 — intervention group
Group type: EXPERIMENTAL
Intervention: US tariff
Number of subjects: 12085
Study 32660494 — intervention group
Group type: EXPERIMENTAL
Intervention: UK tariff
Number of subjects: 12085
Study 32660494 — intervention group
Group type: EXPERIMENTAL
Intervention: Japanese tariff
Number of subjects: 12085
Study 35683991 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish powder
Number of subjects: 238
Study 35683991 — intervention group
Group type: COMPARATOR
Intervention: Sorghum powder (control)
Number of subjects: 238
Study 33765912 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg/month (240 mg loading dose)
Number of subjects: 462
Study 34776146 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program (MCEP) performed twice weekly for two months
Number of subjects: 40
Study 34776146 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) did not perform any exercise intervention
Number of subjects: 40
Study 32408817 — intervention group
Group type: EXPERIMENTAL
Intervention: IMR > 40
Number of subjects: 440
Study 32408817 — intervention group
Group type: EXPERIMENTAL
Intervention: RRR
Number of subjects: 440
Study 32408817 — intervention group
Group type: EXPERIMENTAL
Intervention: CFR
Number of subjects: 440
Study 33857789 — intervention group
Group type: EXPERIMENTAL
Intervention: Apixaban
Number of subjects: 130
Study 33857789 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 32013332 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 220
Study 32013332 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane
Number of subjects: 220
Study 32852574 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (40 mg BID) + innovative pelvic floor muscle training (iPFMT)
Number of subjects: 158
Study 32852574 — intervention group
Group type: COMPARATOR
Intervention: Duloxetine (40 mg BID)
Number of subjects: 158
Study 36448245 — intervention group
Group type: EXPERIMENTAL
Intervention: SDM intervention
Number of subjects: 100
Study 36448245 — intervention group
Group type: COMPARATOR
Intervention: No discernible SDM form
Number of subjects: 100
Study 36448245 — intervention group
Group type: COMPARATOR
Intervention: One SDM form
Number of subjects: 100
Study 36448245 — intervention group
Group type: COMPARATOR
Intervention: Two SDM forms
Number of subjects: 100
Study 36448245 — intervention group
Group type: COMPARATOR
Intervention: Three or more SDM forms
Number of subjects: 100
Study 36448245 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 100
Study 34050197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose 1 Curry (D1C) - 6g mixed spices
Number of subjects: 15
Study 34050197 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose 2 Curry (D2C) - 12g mixed spices
Number of subjects: 15
Study 34050197 — intervention group
Group type: COMPARATOR
Intervention: Dose 0 Control (D0C) - low-polyphenol, no spices
Number of subjects: 15
Study 35190536 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie-restricted modified MIND diet
Number of subjects: 40
Study 35190536 — intervention group
Group type: COMPARATOR
Intervention: Calorie-restricted standard control diet
Number of subjects: 40
Study 33326969 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-selective carious tissue removal (NSCR)
Number of subjects: 107
Study 33326969 — intervention group
Group type: COMPARATOR
Intervention: Selective carious tissue removal (SCR)
Number of subjects: 107
Study 32675074 — intervention group
Group type: EXPERIMENTAL
Intervention: Real training with BCI to control a virtual hand image
Number of subjects: 12
Study 32675074 — intervention group
Group type: COMPARATOR
Intervention: Random training with the same hand image controlled by randomly changing values
Number of subjects: 12
Study 36242060 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole brain radiation therapy for synchronous brain metastases with irradiation protecting the hippocampus
Number of subjects: 102
Study 36242060 — intervention group
Group type: COMPARATOR
Intervention: Whole brain radiotherapy for sequential brain metastases to boost irradiation
Number of subjects: 102
Study 32900266 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute ketamine dosing
Number of subjects: 24
Study 32900266 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance ketamine therapy (1 mg/kg, once or twice weekly for 3 months)
Number of subjects: 24
Study 35522253 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Group (PAG) - two weekly group exercise sessions and two to three home-based exercise sessions per week
Number of subjects: 56
Study 34900188 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted nursing intervention centering on narrative nursing (Group A)
Number of subjects: 120
Study 34900188 — intervention group
Group type: COMPARATOR
Intervention: Targeted nursing intervention (Group B)
Number of subjects: 120
Study 33295128 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral erector spinae plane block using 20 mL bupivacaine 0.25% at the level of the T7 transverse process
Number of subjects: 60
Study 33295128 — intervention group
Group type: COMPARATOR
Intervention: Bilateral sham block using 20 mL normal saline
Number of subjects: 60
Study 32410819 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed-dose combination of 150 mg of econazole with 6 mg of benzydamine
Number of subjects: 100
Study 32410819 — intervention group
Group type: COMPARATOR
Intervention: Econazole single-drug formulation
Number of subjects: 100
Study 32410819 — intervention group
Group type: COMPARATOR
Intervention: Benzydamine single-drug formulation
Number of subjects: 100
Study 32410819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35797104 — intervention group
Group type: EXPERIMENTAL
Intervention: FutureMe intervention (physical activity and food purchase tracking mobile phone app with future-self avatar)
Number of subjects: 95
Study 35797104 — intervention group
Group type: EXPERIMENTAL
Intervention: FutureMe intervention
Number of subjects: 95
Study 35797104 — intervention group
Group type: COMPARATOR
Intervention: Control group (conventional text- and graphic-based primary interface intervention)
Number of subjects: 95
Study 35797104 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 95
Study 34293615 — intervention group
Group type: EXPERIMENTAL
Intervention: FFC group: tap water containing FFC (0.15g/L) given daily for 5 days
Number of subjects: 60
Study 34293615 — intervention group
Group type: COMPARATOR
Intervention: Control group: normal drinking water and feed given daily
Number of subjects: 60
Study 36186931 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg Crocus sativus capsules twice daily
Number of subjects: 74
Study 36186931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 74
Study 32229745 — intervention group
Group type: EXPERIMENTAL
Intervention: Small-fragment plating (3.5-mm locking compression plate)
Number of subjects: 122
Study 32229745 — intervention group
Group type: COMPARATOR
Intervention: Mini-fragment plating (2.7-mm reconstruction plates)
Number of subjects: 122
Study 32229745 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini-fragment plating
Number of subjects: 122
Study 32229745 — intervention group
Group type: COMPARATOR
Intervention: Small-fragment plating
Number of subjects: 122
Study 32229745 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups combined
Number of subjects: 122
Study 32229745 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 122
Study 35704951 — intervention group
Group type: COMPARATOR
Intervention: Lu AF11167 3-4mg
Number of subjects: 162
Study 35704951 — intervention group
Group type: COMPARATOR
Intervention: Lu AF11167 1-2mg
Number of subjects: 162
Study 35704951 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo
Number of subjects: 162
Study 35704951 — intervention group
Group type: COMPARATOR
Intervention: Lu AF11167 (both doses)
Number of subjects: 162
Study 32354987 — intervention group
Group type: EXPERIMENTAL
Intervention: Canagliflozin 100 mg
Number of subjects: 4401
Study 32354987 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4401
Study 36630000 — intervention group
Group type: EXPERIMENTAL
Intervention: mAFA intervention (mobile health technology integrated care based on the ABC pathway)
Number of subjects: 3324
Study 36630000 — intervention group
Group type: EXPERIMENTAL
Intervention: mAFA intervention
Number of subjects: 3324
Study 32926423 — intervention group
Group type: EXPERIMENTAL
Intervention: Thermal softening of endotracheal tubes
Number of subjects: 196
Study 32926423 — intervention group
Group type: COMPARATOR
Intervention: Control group (endotracheal tubes without thermal softening)
Number of subjects: 196
Study 32089436 — intervention group
Group type: EXPERIMENTAL
Intervention: Anterior circulation ICAS
Number of subjects: 449
Study 32089436 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior circulation ICAS
Number of subjects: 449
Study 35297136 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness (measured by Child and Adolescent Mindfulness Measure - CAMM)
Number of subjects: 152
Study 35297136 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness (measured by CAMM)
Number of subjects: 152
Study 34587980 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation and coping strategies in boys with Barth syndrome as explored through qualitative interviews.
Number of subjects: 11
Study 34587980 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative exploration of interpersonal processes in family life related to Barth syndrome.
Number of subjects: 11
Study 32193277 — intervention group
Group type: EXPERIMENTAL
Intervention: BLTR with a 3 mm incision height
Number of subjects: 0
Study 32193277 — intervention group
Group type: EXPERIMENTAL
Intervention: BLTR with a 5 mm incision height
Number of subjects: 0
Study 32193277 — intervention group
Group type: EXPERIMENTAL
Intervention: PLTR with a 3 mm incision height
Number of subjects: 0
Study 36054287 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative FOCUS
Number of subjects: 338
Study 36054287 — intervention group
Group type: COMPARATOR
Intervention: No preoperative FOCUS (Control)
Number of subjects: 338
Study 32299300 — intervention group
Group type: EXPERIMENTAL
Intervention: Quill self‐retaining sutures
Number of subjects: 52
Study 32299300 — intervention group
Group type: EXPERIMENTAL
Intervention: Retromuscular mesh
Number of subjects: 52
Study 32299300 — intervention group
Group type: COMPARATOR
Intervention: Both surgical groups
Number of subjects: 52
Study 35793881 — intervention group
Group type: EXPERIMENTAL
Intervention: Short needling
Number of subjects: 68
Study 35793881 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 68
Study 33979487 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanostomy-tube placement
Number of subjects: 0
Study 33979487 — intervention group
Group type: COMPARATOR
Intervention: Medical management (episodic antimicrobial treatment)
Number of subjects: 0
Study 33979487 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanostomy-tube placement (per-protocol analysis)
Number of subjects: 0
Study 33979487 — intervention group
Group type: COMPARATOR
Intervention: Medical management (per-protocol analysis)
Number of subjects: 0
Study 33979487 — intervention group
Group type: COMPARATOR
Intervention: Medical management
Number of subjects: 0
Study 33979487 — intervention group
Group type: EXPERIMENTAL
Intervention: Tympanostomy-tube placement and Medical management
Number of subjects: 0
Study 32250190 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical olopatadine hydrochloride 0.1%
Number of subjects: 77
Study 32250190 — intervention group
Group type: COMPARATOR
Intervention: Sterile distilled water (control)
Number of subjects: 77
Study 35802177 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised Kegel exercises with bio-feedback training (BT)
Number of subjects: 29
Study 35802177 — intervention group
Group type: COMPARATOR
Intervention: Unsupervised Kegel exercises
Number of subjects: 29
Study 34535867 — intervention group
Group type: EXPERIMENTAL
Intervention: Conflicting health information
Number of subjects: 184
Study 34535867 — intervention group
Group type: COMPARATOR
Intervention: Congruent health information
Number of subjects: 184
Study 32041812 — intervention group
Group type: EXPERIMENTAL
Intervention: Education and multilevel social comparison feedback intervention
Number of subjects: 14000
Study 32041812 — intervention group
Group type: COMPARATOR
Intervention: Control units (MTUs of the remaining three sites)
Number of subjects: 14000
Study 35109889 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangxianhuanji granule, 10 g each time, two times daily for 4 weeks
Number of subjects: 80
Study 35109889 — intervention group
Group type: COMPARATOR
Intervention: Placebo granule, 10 g each time, two times daily for 4 weeks
Number of subjects: 80
Study 35109889 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangxianhuanji granule
Number of subjects: 80
Study 35109889 — intervention group
Group type: COMPARATOR
Intervention: Placebo granule
Number of subjects: 80
Study 34552099 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine monotherapy
Number of subjects: 57
Study 34552099 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus ATR inhibitor (berzosertib)
Number of subjects: 57
Study 35324259 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Worker (CHW) program
Number of subjects: 2457
Study 35324259 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 2457
Study 32147894 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinyin GraphoGame intervention for 3 weeks
Number of subjects: 56
Study 32147894 — intervention group
Group type: COMPARATOR
Intervention: Control group received school instruction only for 3 weeks
Number of subjects: 56
Study 32147894 — intervention group
Group type: EXPERIMENTAL
Intervention: Pinyin GraphoGame intervention
Number of subjects: 56
Study 34890346 — intervention group
Group type: EXPERIMENTAL
Intervention: Gamification training method
Number of subjects: 123
Study 34890346 — intervention group
Group type: EXPERIMENTAL
Intervention: Teach-back training method
Number of subjects: 123
Study 34890346 — intervention group
Group type: COMPARATOR
Intervention: Control group (usual care)
Number of subjects: 123
Study 35419986 — intervention group
Group type: EXPERIMENTAL
Intervention: rhTNFR:Fc PFS (prefilled syringe)
Number of subjects: 82
Study 35419986 — intervention group
Group type: COMPARATOR
Intervention: rhTNFR:Fc LYO (lyophilized)
Number of subjects: 82
Study 35419986 — intervention group
Group type: EXPERIMENTAL
Intervention: Both formulations (rhTNFR:Fc PFS and LYO)
Number of subjects: 82
Study 33418457 — intervention group
Group type: COMPARATOR
Intervention: SPN-812 (viloxazine extended-release) 100-600 mg/day
Number of subjects: 1397
Study 35094667 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg·kg‐1 caffeine + 10% maltodextrin (CHO+CAFMR)
Number of subjects: 9
Study 35094667 — intervention group
Group type: EXPERIMENTAL
Intervention: 6 mg·kg‐1 caffeine (CAFMR)
Number of subjects: 9
Study 35094667 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% maltodextrin (CHOMR)
Number of subjects: 9
Study 35094667 — intervention group
Group type: COMPARATOR
Intervention: Water (PLA)
Number of subjects: 9
Study 32734457 — intervention group
Group type: EXPERIMENTAL
Intervention: 68Ga-PSMA-11 PET/CT
Number of subjects: 120
Study 32734457 — intervention group
Group type: COMPARATOR
Intervention: TRUS-GB
Number of subjects: 120
Study 36181783 — intervention group
Group type: EXPERIMENTAL
Intervention: Intuity
Number of subjects: 375
Study 36181783 — intervention group
Group type: COMPARATOR
Intervention: ME
Number of subjects: 375
Study 34938848 — intervention group
Group type: EXPERIMENTAL
Intervention: Take Care of Me program (8-week online integrated treatment with 12 modules)
Number of subjects: 222
Study 34938848 — intervention group
Group type: EXPERIMENTAL
Intervention: Take Care of Me program
Number of subjects: 222
Study 34938848 — intervention group
Group type: COMPARATOR
Intervention: Online psychoeducational control condition
Number of subjects: 222
Study 35830497 — intervention group
Group type: COMPARATOR
Intervention: Fitbit Charge HR 3 alone (FB)
Number of subjects: 44
Study 35830497 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitbit in combination with behaviour change strategies (FB+)
Number of subjects: 44
Study 32135143 — intervention group
Group type: EXPERIMENTAL
Intervention: Expedited partner therapy awareness
Number of subjects: 335
Study 32135143 — intervention group
Group type: EXPERIMENTAL
Intervention: Expedited partner therapy prescription receipt
Number of subjects: 335
Study 32135143 — intervention group
Group type: EXPERIMENTAL
Intervention: Willingness to dispense expedited partner therapy prescriptions
Number of subjects: 335
Study 32135143 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of azithromycin for chlamydia treatment
Number of subjects: 335
Study 32135143 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost of cefixime for gonorrhea treatment
Number of subjects: 335
Study 35600047 — intervention group
Group type: EXPERIMENTAL
Intervention: Predictive model based on Cox regression analysis
Number of subjects: 1762
Study 35600047 — intervention group
Group type: EXPERIMENTAL
Intervention: Training set analysis
Number of subjects: 1762
Study 35600047 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up of patients
Number of subjects: 1762
Study 34006157 — intervention group
Group type: EXPERIMENTAL
Intervention: Telemedicine
Number of subjects: 198
Study 34006157 — intervention group
Group type: COMPARATOR
Intervention: In-person services
Number of subjects: 198
Study 34006157 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare delivery changes due to COVID-19
Number of subjects: 198
Study 33644992 — intervention group
Group type: COMPARATOR
Intervention: Repository corticotropin injection (RCI) 80 units twice weekly for 12 weeks, followed by either RCI or placebo for another 12 weeks.
Number of subjects: 0
Study 34663438 — intervention group
Group type: EXPERIMENTAL
Intervention: Turmeric (2 gr/day)
Number of subjects: 64
Study 34663438 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 34118699 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended-release naltrexone (XR-NTX)
Number of subjects: 288
Study 34118699 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual (TAU)
Number of subjects: 288
Study 32851513 — intervention group
Group type: EXPERIMENTAL
Intervention: Desflurane (6.0 vol%)
Number of subjects: 24
Study 32851513 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (1.7 vol%)
Number of subjects: 24
Study 32851513 — intervention group
Group type: COMPARATOR
Intervention: Control (human lung)
Number of subjects: 24
Study 32851513 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygenator groups (Terumo, LivaNova, Medtronic, Senko)
Number of subjects: 24